Genesis Healthcare is controlled by ReGen Healthcare, LLC, a private equity-backed investment vehicle run by New York investor Joel Landau and affiliated with Pinta Capital Partners. Through roughly $100 million in convertible note investments made between 2021 and 2023, ReGen accumulated about 93% of Genesis’s voting equity.1U.S. Senate. Warren, Blumenthal, Welch, Goodlander Investigate Genesis Healthcare Private Equity Bankruptcy and Its Impact on Nursing Home and Assisted Living Residents Across the Country That answer comes with a caveat: Genesis filed for Chapter 11 in July 2025, and a bankruptcy judge rejected ReGen’s attempt to buy the assets outright, ordering a new auction. Who ultimately owns Genesis’s roughly 195 facilities is not yet settled.
How ReGen Reached 93% Ownership
ReGen’s stake was built in stages. It started in March 2021 with a $50 million investment structured as a convertible note, giving ReGen an initial 25% interest in Genesis’s operating subsidiaries and an option for another $25 million that could push ownership to about 43%.2Genesis HealthCare. Genesis Healthcare Announces Strategic Restructuring Steps to Strengthen Balance Sheet and Chart Path for Recovery
Landau kept adding. ReGen put in another $10 million in December 2022, $15 million in January 2023, and $25 million in May 2023. By the time the final note was issued, the convertible notes gave ReGen rights to roughly 93% of Genesis’s voting shares.1U.S. Senate. Warren, Blumenthal, Welch, Goodlander Investigate Genesis Healthcare Private Equity Bankruptcy and Its Impact on Nursing Home and Assisted Living Residents Across the Country Alongside the equity, ReGen picked up the right to name board members, giving Landau direct control over Genesis’s strategic direction.
One detail matters for understanding the structure. Genesis Healthcare, Inc. is a holding company, but the actual nursing homes are run by hundreds of operating subsidiaries. ReGen’s equity sits at the subsidiary level, meaning Landau controls the entities that run the facilities rather than the publicly listed shell alone. Genesis also voluntarily delisted from the NYSE as part of the 2021 restructuring; its shares now trade on the OTC Pink market under the ticker GENNQ, where reporting requirements are minimal.
Why Owning Genesis Is Not the Same as Owning Its Buildings
Anyone asking who owns Genesis needs to separate two questions: who owns the company, and who owns the physical facilities the company operates in. Those are not the same parties. Most of Genesis’s buildings are owned by real estate investment trusts that lease them back to Genesis under long-term master lease agreements. Rent is one of Genesis’s largest fixed costs, and lease terms often include annual escalators that push rent higher regardless of how the business performs.
Welltower Inc. was historically one of Genesis’s largest landlords. In 2021, Welltower terminated its master lease covering 51 Genesis-operated facilities, paying Genesis an $86 million termination fee and forgiving $170 million in debt in exchange for an equity interest in the company.3Welltower Investor Relations. Welltower Announces Substantial Exit of Genesis HealthCare Operating Relationship
Sabra Health Care REIT followed a similar path. In late 2017, Sabra completed the sale of 20 facilities that had been leased to Genesis across Kentucky, Ohio, and Indiana for $103.3 million, cutting Genesis’s annual rent to Sabra by $9.3 million. Those 20 properties were part of a larger group of 35 that Sabra had been marketing for sale under agreements with Genesis.4GlobeNewsWire. Sabra Health Care REIT, Inc. Completes the Sale of 20 Facilities Leased to Genesis
LTC Properties remains a current landlord. Genesis affiliates lease six skilled nursing centers from LTC under a master lease originally set to expire in April 2026. Genesis exercised a five-year extension option in June 2025, pushing the term to April 2031. LTC’s annualized revenue from Genesis was $8.4 million as of early 2025, about 4.5% of LTC’s total revenue, and LTC holds $4.7 million in security from Genesis under the lease.5LTC Properties. LTC Operator Files for Bankruptcy
The practical effect: when Genesis struggles financially, it cannot sell buildings to raise cash because it does not own them. The operator is locked into lease obligations that keep ticking even as revenue drops.
The 2025 Chapter 11 and the Rejected Sale
On July 9, 2025, Genesis Healthcare, Inc. and 298 of its affiliates and subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Northern District of Texas.6Epiq. Genesis Healthcare Bankruptcy Overview The company entered bankruptcy with more than $2.2 billion in total debt, roughly $708 million of it secured and over $1.5 billion in unsecured claims.
ReGen, already holding 93% of the equity, positioned itself as the stalking horse bidder to acquire Genesis’s assets out of bankruptcy. A stalking horse bid sets the floor price at a bankruptcy auction and comes with structural advantages for the bidder. In this case, Landau was seeking to buy the assets through a new entity he controlled while also obtaining legal releases that would shield him from personal liability.
That plan did not hold up. In December 2025, U.S. Bankruptcy Judge Stacey G.C. Jernigan rejected the proposed sale, citing “too many irregularities” in the auction process. The U.S. Trustee’s Office and the Official Committee of Unsecured Creditors had both objected to the sale terms, and the judge declined to approve the legal releases Landau had sought. She ordered a new auction to be conducted in January 2026 under the oversight of the U.S. Trustee’s Office.
By late February 2026, the case was running longer than planned, and Genesis faced a potential liquidity crisis. The company won court approval for a debtor-in-possession loan of up to $105 million from its existing lenders, with an initial draw of $80 million authorized to cover payroll and rent coming due in March. The bankruptcy remains active, and the ultimate ownership of Genesis’s facilities and operations has not been resolved.
Who Runs the Company Right Now
ReGen has controlled Genesis’s board and executive suite since 2021. As part of its initial $50 million investment, ReGen gained the right to appoint two members of the board. Two existing directors stepped down, and ReGen installed David Harrington as Chairman of the Board and John Randazzo as a director.7SEC. Genesis Healthcare Inc – SEC Filing Exhibit 99.1 ReGen picked up an additional board seat with its May 2023 investment, giving Landau’s team three seats and firm control over corporate governance.
On the management side, Genesis replaced CEO Robert Fish with Harry Wilson, a turnaround specialist who had previously helped restructure General Motors during its government bailout. The company described the broader leadership change as a complete transformation of the executive team over a three-year period.8Genesis HealthCare. Genesis Healthcare Remains Committed to Securing Longterm Stability
What Could Change the Ownership Picture
The court-ordered new auction is the event that could shift ownership away from ReGen. Until that auction runs and a sale is approved, the board and management installed by ReGen continue to oversee day-to-day operations. If a different bidder wins the assets, control of Genesis’s roughly 195 facilities across 19 states will move to that buyer. If ReGen wins under revised terms the judge will accept, Landau’s control continues in a new corporate wrapper. Either way, the answer to who owns Genesis Healthcare will be different from the answer that applied on the day of filing, and it will be set by the bankruptcy court rather than by a private transaction.